Diary

  • Mon
    04
    Jul
    2022

    10am - 12.30pmOnline, live event

    Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: This morning Elaine provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people with malignant melanoma. She begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.

    Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses

    Cost: £50

    To book, contact: conferenceteam@rmh.nhs.uk
    View a PDF of the programme

  • Tue
    05
    Jul
    2022

    10am - 12.30pmOnline, live event

    Format: This is a live, virtual event. Each morning’s content is split over three sessions of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each presentation. Recordings of the presentations will be available online for 30 days after the live event.

    Description: In this course Elaine provides an up-to-date overview of bowel cancer biology and genetics and the science behind various treatment approaches. Including monoclonal antibodies targeting EGFR, and small molecule such as B-Raf inhibitors. She also describes the rationale behind checkpoint inhibitors for selected patients, and discusses treatment approaches in trials.

    Elaine's goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses

    Cost: £50

    To book, contact: conferenceteam@rmh.nhs.uk

    View a PDF of the programme

  • Tue
    06
    Sep
    2022

    All dayCentral London


    Format:
    This study day will be held in central London from approx. 10am - 4.30pm.

    Description: This course is designed specifically for those new to cancer, or those wishing to refresh their knowledge. In the morning Elaine looks at the mechanisms of action of chemotherapy, hormone therapy, targeted therapy and immunotherapy. In the afternoon, she describes what biomarkers are, where they’re found, how they’re detected, and what they’re used for.

    Audience: This course is ideal for nurses who are new to caring for cancer patients or who wish to refresh and expand their knowledge. This course is also suitable for anyone involved in cancer research and trials.

    Cost: £150 (materials will be available online for the following 30 days)
    To book, contact: conferenceteam@rmh.nhs.uk

    View the programme

     

  • Tue
    29
    Nov
    2022

    9.15am - 4pmCentral London


    Description:
    Throughout the day, Elaine will guide you through the scientific concepts that underpin many of the most prescribed targeted treatments & immunotherapies for people with solid tumours.

    Treatments include a wide variety of antibody-based therapies targeting cell surface proteins and small molecules targeting various kinases and other proteins involved in cell communication. Elaine will discuss progress to date with checkpoint inhibitors and describe other forms of immunotherapy such as treatment vaccines, CAR T cells and TCR-modified T cells.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £150 (materials will be available online for the following 30 days)
    To book, contact: conferenceteam@rmh.nhs.uk
    View a PDF of the programme